{"disease":{"id":"retinal-dystrophy","name":"retinal dystrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04131400","title":"Establishment of the National Registry for Inherited Retinal Dystrophy in Iran","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Shahid Beheshti University of Medical Sciences","has_results":false},{"nct_id":"NCT05130385","title":"High Resolution Optical Coherence Tomography","phase":"","overall_status":"UNKNOWN","enrollment_count":550,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT03613948","title":"Study on the Effects of Mutations Under Inherited Retinal Disease in Korean","phase":"","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"Gangnam Severance Hospital","has_results":false},{"nct_id":"NCT07082855","title":"A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":126,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05793515","title":"Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Istituto Superiore di Sanità","has_results":false},{"nct_id":"NCT05355415","title":"Adaptive Optics Imaging of Outer Retinal Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Food and Drug Administration (FDA)","has_results":false},{"nct_id":"NCT03597399","title":"A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US","phase":"","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"Spark Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06743646","title":"Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":62,"lead_sponsor_name":"Chigenovo Co., Ltd","has_results":false},{"nct_id":"NCT04545736","title":"Oral Metformin for Treatment of ABCA4 Retinopathy","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT05573984","title":"Natural History of PRPF31 Mutation-Associated Retinal Dystrophy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"PYC Therapeutics","has_results":false},{"nct_id":"NCT06908161","title":"Functional Assessments in Vision Impairment","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Center for Eye Research Australia","has_results":false},{"nct_id":"NCT05820100","title":"Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT","phase":"","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Nanoscope Therapeutics Inc.","has_results":false},{"nct_id":"NCT04068207","title":"Minocycline Treatment in Retinitis Pigmentosa","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04224207","title":"Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Ankara Universitesi Teknokent","has_results":false},{"nct_id":"NCT05626920","title":"Disulfiram for Treatment of Retinal Degeneration","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT05902962","title":"SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"PYC Therapeutics","has_results":false},{"nct_id":"NCT07063030","title":"A Study of LX107 Gene Therapy in AIPL1-IRD Patients","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":13,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT06706427","title":"Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy Subjects","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":12,"lead_sponsor_name":"NGGT (Suzhou) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT05976139","title":"Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Fondazione G.B. Bietti, IRCCS","has_results":false},{"nct_id":"NCT05858983","title":"Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Frontera Therapeutics","has_results":false},{"nct_id":"NCT02723448","title":"Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04516369","title":"Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03561922","title":"Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS","phase":"NA","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Retina Implant AG","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}